Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
Vistagen Therapeutics, Inc. (NASDAQ: VTGN)
VTGN Stock Predictions and Ratings
WSX Rating:
STRONG SELL
WSX Forecast (1yr):
-50.30%
Analyst Rating:
HOLD
Analyst Forecast (1yr):
-19.70%
VTGN Stock Analysis
VTGN
PE Ratio:
VTGN
PEG Ratio:
Not Available
VTGN
Forward EPS Growth (12 month):
0.00%
VTGN
PS Ratio:
23.4
VTGN
PSG Ratio:
-0.5
VTGN
Forward Revenue Growth (12 month):
-43.30%
VTGN Articles
No data was found